在沙特阿拉伯麦加市对阿尔茨海默病的公众意识,知识和态度
Jihad Muglan1, Reem M Alkhaldi2, Manar M Alsharif2
1Department of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Cureus
|December 20, 2023
概括
公众对阿尔茨海默病的认识令人担忧地低,麦加的大多数人表现出缺乏知识. 提高公众教育对于早期发现这种神经退行性疾病至关重要.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响认知功能,特别是在老年人群中.
- 早期识别AD症状对于及时的医疗干预和管理至关重要.
研究的目的:
- 评估沙特阿拉伯麦加市普通人口对阿尔茨海默病的认识,知识和态度.
- 确定影响公众对阿尔茨海默病的理解的因素.
主要方法:
- 一项采用在线问卷分发给麦加的545名参与者进行的横截面研究.
- 用阿尔茨海默氏病知识量表 (ADKS) 评估知识水平,认知程度分为低 (<60%) 或高 (≥60%).
主要成果:
- 绝大多数 (87.5%) 的参与者对阿尔茨海默病的了解和认识很差.
- 与已婚受访者 (8.3%) 相比,离婚者/寡妇 (16.2%) 的知识水平更高 (P=.049).
- 患有阿尔茨海默氏症家族病史的参与者比没有阿尔茨海默氏症的参与者 (10.7%) (P=.009) 有更好的知识 (20.4%) (P=.009).
结论:
- 在麦加,关于阿尔茨海默病的公众意识和知识存在重大缺陷.
- 建议开展公共卫生活动和教育举措,以提高对阿尔茨海默病的了解并促进早期诊断.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
相关概念视频
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
